Navigation Links
Watson Confirms Exalgo™ Patent Challenge
Date:12/14/2010

MORRISTOWN, N.J., Dec. 14, 2010 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.  Watson's Hydromorphone Hydrochloride Extended-release Tablets are a generic version of Mallinckrodt Inc.'s Exalgo™ tablets, which are indicated for once daily administration for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.

Mallinckrodt filed suit against Watson on December 10, 2010 in the United States District Court for the District of New Jersey seeking to prevent Watson from commercializing its product prior to the expiration of U.S. Patent No. 5,914,131.  Mallinckrodt's lawsuit was filed under the provisions of the Hatch-Waxman Act, resulting in a stay of final FDA approval of Watson's ANDA until April 29, 2013, or until final resolution of the matter before the court, whichever occurs sooner, subject to any other exclusivities.  

Based on available information, Watson believes it may be a "first applicant" to file an ANDA for the 8 mg, 12 mg, and 16 mg generic versions of Exalgo™ and, should its ANDA be approved, may be entitled to 180 days of generic market exclusivity.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is a leading global specialty pharmaceutical company.  The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health.  Watson has operations in many of the world's established an
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Biosensors International Group, Ltd. ("Biosensors " or ... a developer, manufacturer and marketer of innovative medical devices, ... ("Q4 FY15") and fiscal full year ended 31 March ... , Q4 FY15: , Total revenue ... of Fiscal Year 2014 ("Q4 FY14") due to licensing ...
(Date:5/27/2015)... 27, 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: ... , the company,s president and chief executive officer, will ... week in New York City.  The presentation, which will ... at 11:30 a.m. EDT. To access the ... to the Company,s website at http://www.pdl.com and ...
(Date:5/27/2015)... International, Inc. (NASDAQ: BDSI ) announced that Dr. Mark ... present at two important upcoming healthcare conferences: ... Time Grand Hyatt, New York City , ... Growth Stock Conference Tuesday, June 9 2:50 PM Central Time (3:50 ... , Dr. Sirgo will be discussing progress with ...
Breaking Medicine Technology:Biosensors Reports Financial Results for Fiscal Year 2015 2Biosensors Reports Financial Results for Fiscal Year 2015 3Biosensors Reports Financial Results for Fiscal Year 2015 4Biosensors Reports Financial Results for Fiscal Year 2015 5Biosensors Reports Financial Results for Fiscal Year 2015 6Biosensors Reports Financial Results for Fiscal Year 2015 7PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference 3
... Inc., (IBI), a privately held biopharmaceutical company that ... ophthalmic pharmaceuticals, today announced that Wendy Yee Murahashi, ... as Vice-President, Clinical Development.  Dr. Murahashi will lead ... proprietary Verisome® drug delivery technology. ...
... 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ... and chief operating officer, is scheduled to present a ... in New York City on Wednesday, December 14th at ... http://photos.prnewswire.com/prnh/20030226/RIGLLOGO ) To access the live ...
Cached Medicine Technology:Icon Appoints Murahashi Vice President, Clinical Development 2
(Date:5/27/2015)... Holly CaSaroll, founder of FACE, the award-winning beauty ... cancer. The skin is the body’s largest organ and is ... 3.5 million cases of skin cancer are diagnosed in the ... sun's ultraviolet rays (UVR). , There are several things ... Avoid the sun between the hours of 10 AM and ...
(Date:5/27/2015)... Antonio, TX (PRWEB) May 27, 2015 ... “Pass The Torch” Addiction Treatment Scholarship Award. From June ... awarded $10,000 to 50 drug and alcohol addiction treatment ... afford treatment. Scholarships were drawn at random at addiction ... Director for Sky Toxicology, Matt Green said, “Sky Toxicology ...
(Date:5/27/2015)... Aliso Viejo, CA (PRWEB) May 27, 2015 ... from Pixel Film Studios, editors can quickly and easily add ... 60 cross processed CUBE LUT files. , FCPX LUT Cross ... look from vintage to contemporary looks and everything in between. ... and they can be used in many different softwares. With ...
(Date:5/27/2015)... 2015 National Healthcare Providers ... winning web development and interactive marketing agency, ... launch of its newly redesigned, custom website, ... Healthcare Providers, is a physician owned and ... areas of Radiology, Anesthesiology, Emergency and Hospital ...
(Date:5/27/2015)... 2015 The report “Premature Ejaculation ... on the therapeutic development for Premature Ejaculation. Premature ... sooner during intercourse. Premature ejaculation is a common ... by identifying new targets and MOAs to produce ... 2015 pipeline review of Premature Ejaculation with 23 ...
Breaking Medicine News(10 mins):Health News:In Recognition of National Melanoma Awareness Month, Beauty Guru Details Skin Tips to Prevent Cancer and Premature Aging 2Health News:Sky Toxicology Reaches Their $500,000 Goal in Drug and Alcohol Addiction Treatment Patient Scholarship Awards 2Health News:Sky Toxicology Reaches Their $500,000 Goal in Drug and Alcohol Addiction Treatment Patient Scholarship Awards 3Health News:Developers at Pixel Film Studios Release FCPX LUT Cross Processed Plugin for Final Cut Pro X 2Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 2Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 3Health News:Premature Ejaculation Therapeutic Development and Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Premature Ejaculation Therapeutic Development and Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Premature Ejaculation Therapeutic Development and Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4
... Care with Visibility into Location of Medical Equipment and ... ... 25 Colubris Networks, the leading,global provider of intelligent wireless LANs ... working with,AeroScout, Inc., the leading provider of Unified Asset Visibility,solutions, to ...
... and Increased Uptake of, CellCept Will Provide Effective ... ... WALTHAM, Mass., Feb. 25 Decision Resources, one of ... finds that the entry and uptake of high-priced branded,agents will ...
... Manhattan-based facial plastic,surgeon and Director of The Aesthetic Facial ... M.D., offers his skill and compassion to a,Brooklyn, New ... not covered by her health insurance., Lisa, 26, ... large and disfiguring tumorous-like growths, or keloids, on all,areas ...
... 25 Meddius, an emerging,provider of integration ... and professional services to assist with the,deployment ... hospitals with a Web-based, automated approach to ... (HAIs). The announcement,was made today at the ...
... The Anti-Aging Market, VIRGINIA BEACH, Va., Feb. ... science of LED (light emitting diode),Photomodulation, announced today ... a 510(k) over-the-counter (OTC) clearance from the United ... of periorbital,wrinkles. This clearance paves the way for ...
... Ensure the Body,s Peak ... Performance When You Need it Most, DOYLESTOWN, Pa., Feb. 25 ... healthy immune system.,Keeping the immune system working at its peak is ... that our immune system is easily affected by a number,of factors ...
Cached Medicine News:Health News:Colubris Partners with AeroScout to Enable Real-time Location Detection over Wireless Networks 2Health News:Colubris Partners with AeroScout to Enable Real-time Location Detection over Wireless Networks 3Health News:Uptake of Branded Agents Will Drive the Systemic Lupus Erythematosus Drug Market to Quadruple to $1.4 Billion in 2016 2Health News:New York Plastic Surgeon Performs Pro Bono Surgery on Disadvantaged Patient Where Health Insurance Coverage Was Denied 2Health News:Meddius Signs Agreement to Deliver an Integration Platform for Premier's SafetySurveillor(TM) 2Health News:FDA Grants Over-The-Counter Clearance to GentleWaves(R) for the First Home Use Light-Based Device to Treat Wrinkles 2Health News:FDA Grants Over-The-Counter Clearance to GentleWaves(R) for the First Home Use Light-Based Device to Treat Wrinkles 3Health News:FDA Grants Over-The-Counter Clearance to GentleWaves(R) for the First Home Use Light-Based Device to Treat Wrinkles 4Health News:Prime Your Immune System During the Peak of Cold Season and Beyond 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: